Can a Weight-Loss drug protect bones and strength in seniors?
NCT ID NCT06861439
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 34 times
Summary
This pilot study looks at how the weekly medication tirzepatide affects body composition, bone density, and physical abilities in 40 older adults with obesity over nine months. Participants take the drug, track their diet and activity, and attend regular check-ins. The goal is to see if tirzepatide can help reduce fat while preserving muscle and bone health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157, United States
Conditions
Explore the condition pages connected to this study.